Daxor Corporation Signs Agreement With Two Major Medical School Hospitals to Serve as Test Sites for the Blood Volume Analyzer -- BVA-100.NEW YORK--(BUSINESS WIRE)--July 28, 1998--The Daxor Corporation has announced that it has signed an agreement with Presbyterian Medical Center, College of Physicians and Surgeons College of Physicians and Surgeons: see Columbia Univ. of Columbia University as well as Mt. Sinai Hospital of the Mt. Sinai Medical School. The Company also signed an agreement with Good Samaritan Hospital Good Samaritan Hospital may refer to: In the United States:
abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance for marketing. The instrument is capable of measuring the total amount of blood in the human body within 18-35 minutes. Current tests for blood volume measurement are inaccurate in situations of acute blood loss, such as during surgery. The BVA-100 can provide critical information for precise fluid and transfusion replacement therapy. Mt. Sinai Hospital and Presbyterian Medical Center are the primary teaching hospitals for these respective medical schools. These centers have been actively engaged in pioneering medical research concerned with hemodynamics hemodynamics /he·mo·dy·nam·ics/ (-di-nam´iks) the study of the movements of blood and of the forces concerned.hemodynam´ic he·mo·dy·nam·ics n. . In the United States, there are approximately 4 million patients that receive blood transfusions each year. Direct measurement of total blood volume would assist physicians in providing precise blood and fluid replacement therapy. The company expects to announce additional hospitals which will serve as beta test sites for the Blood Volume Analyzer in the near future. The company previously concluded similar agreements with Englewood Hospital and Robert Wood Johnson Robert Wood Johnson was the name shared by members of the family that descended from the President of Johnson & Johnson:
For additional information, contact Jane Kryzanowski, Investor Relations Investor relations The process by which the corporation communicates with its investors. or Dr. Joseph Feldschuh, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. .
CONTACT: Investor Relations:
Jane Kryzanowski
or
Dr. Joseph Feldschuh, President and CEO
212/244-0555
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion